We recently published a list of 15 AI Stocks Surging on News and Analyst Ratings. In this article, we are going to take a ...

Takeda Pharmaceuticals delivered strong FY2024 results and offers value with a 4.81% yield, despite pressure from Vyvanse ...

Dan Gandor, an omnichannel ace who has spent his entire career on the client side of the business, has joined Eversana ...

Takeda was scrambling to accommodate for rapidly sinking profits from the hasty decline of ADHD mainstay Vyvanse with a 140 ...

Christophe Weber, CEO of Takeda Pharma, discusses the group's plans to invest $30 billion into its U.S. operations over the ...

Takeda Pharmaceutical Co Ltd (TSE:4502) is set to release its Q4 2024 earnings on May 8, 2025. The consensus estimate for Q4 ...

TOKYO -- Japanese drugmaker Takeda Pharmaceuticals will invest $30 billion in the U.S. over the next five years, CEO ...

At a recent gathering, experts in the Swiss biotech and pharma sector underscored the power of international alliances.

Investors might want to bet on Takeda Pharmaceutical Co. (TAK), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings ...

Kroger, Albertsons and others allege an unlawful monopoly in one legal case and aim to recover overcharges for a drug in ...

Enhertu delivered a phase 3 trial win in early-stage breast cancer. Takeda spotlighted three late-stage readouts as a ...